SCHEMBL4959972

SCHEMBL4959972

COc1cc(OC)c(O)c(C(=O)O)c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 1/20 0.55
CA1 P00915 1/20 0.55
CA2 P00918 1/20 0.55
CA3 P07451 1/20 0.55
PKM P14618 1/20 0.55
CA4 P22748 1/20 0.55
CA6 P23280 1/20 0.55
CA5A P35218 1/20 0.55
CA7 P43166 1/20 0.55
CA9 Q16790 1/20 0.55
CA14 Q9ULX7 1/20 0.55
CA5B Q9Y2D0 1/20 0.55
PTGS2 P35354 1/20 0.52
KDM4E B2RXH2 4/20 0.49
ALDH1A1 P00352 3/20 0.49
SMN1; SMN2 Q16637 2/20 0.49
MAPT P10636 2/20 0.49
USP2 O75604 1/20 0.49
CYP3A4 P08684 1/20 0.49
MAPK1 P28482 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31208074 1.00 CA12 (0.55) CA12CA1CA2CA3PKM
SCHEMBL31355236 0.88 SMN1; SMN2 (0.52) CA12CA1CA2CA3PKM
SCHEMBL5838887 0.85 CYP3A4 (0.58) CA12CA1CA2CA3PKM
SCHEMBL6465454 0.83 CYP3A4 (0.47) CA12CA1CA2CA3PKM
SCHEMBL15513877 0.82 PKM (0.57) CA12CA1CA2CA3PKM
SCHEMBL18341497 0.82 NPC1 (0.53) CA12CA1CA2CA7CA9
SCHEMBL4847814 0.81 KDM4E (0.53) PKMKDM4EALDH1A1SMN1; SMN2MAPT
SCHEMBL1651653 0.81 KDM4E (0.49) KDM4EALDH1A1SMN1; SMN2MAPTUSP2
SCHEMBL6507929 0.81 SMN1; SMN2 (0.53) CA12CA1CA2CA7CA9
SCHEMBL7824527 0.81 CA12 (0.78) CA12CA1CA2CA3PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250214921-A1 METHOD FOR PRODUCING CYCLIC DIKETONE COMPOUND KAO CORPORATION (JP) 2025-07-03 US disclosed
US-20250214920-A1 METHOD FOR PRODUCING CYCLIC DIKETONE COMPOUND KAO CORPORATION (JP) 2025-07-03 US disclosed
EP-4501897-A1 METHOD FOR PRODUCING CYCLIC DIKETONE COMPOUND Kao Corporation (JP) 2025-02-05 EP disclosed
EP-4501896-A1 METHOD FOR PRODUCING CYCLIC DIKETONE COMPOUND Kao Corporation (JP) 2025-02-05 EP disclosed
WO-2023189723-A1 METHOD FOR PRODUCING CYCLIC DIKETONE COMPOUND 花王株式会社 2023-10-05 WO disclosed
WO-2023189722-A1 METHOD FOR PRODUCING CYCLIC DIKETONE COMPOUND 花王株式会社 2023-10-05 WO disclosed
WO-2019078645-A1 PHARMACEUTICAL COMPOSITION FOR ANTICANCER TREATMENT AND PREPARATION METHOD THEREFOR 충남대학교 산학협력단 2019-04-25 WO disclosed
EP-1871844-B1 BUBBLE COMPOSITION WITH COLOR CHANGING INDICATOR C2C TECHNOLOGIES LLC (US) 2014-08-27 EP disclosed
WO-2010042600-A2 PHOTO-ACTIVATABLE THERAPEUTIC AGENTS AND METHODS OF USING THE UAB RESEARCH FOUNDATION (US) 2010-04-15 WO disclosed
EP-1871844-A2 NOVELTY COMPOSITIONS WITH COLOR CHANGING INDICATOR C2C Technologies LLC (US) 2008-01-02 EP disclosed
US-20070010400-A1 Use of color changing indicators in consumer products C2C TECHNOLOGIES, LLC 2007-01-11 US disclosed
US-20060257439-A1 Cleansing compositions with color changing indicator CRAYOLA LLC 2006-11-16 US disclosed
US-20060236470-A1 Novelty compositions with color changing indicator CRAYOLA LLC 2006-10-26 US disclosed
WO-2006105193-A2 PERSONAL CARE COMPOSITIONS WITH COLOR CHANGING INDICATOR C2C TECHNOLOGIES LLC (US) 2006-10-05 WO disclosed
WO-2006105260-A1 ORAL CARE COMPOSITIONS WITH COLOR CHANGING INDICATOR C2C TECHNOLOGIES LLC (US) 2006-10-05 WO disclosed
WO-2006105261-A1 CLEANSING COMPOSITIONS WITH COLOR CHANGING INDICATOR C2C TECHNOLOGIES LLC (US) 2006-10-05 WO disclosed
WO-2006105191-A2 NOVELTY COMPOSITIONS WITH COLOR CHANGING INDICATOR C2C TECHNOLOGIES LLC (US) 2006-10-05 WO disclosed
US-20060222675-A1 Personal care compositions with color changing indicator C2C TECHNOLOGIES, LLC 2006-10-05 US disclosed
US-20060222601-A1 Oral care compositions with color changing indicator C2C TECHNOLOGIES, LLC 2006-10-05 US disclosed
CN-85107017-A Preparation three ring pyridazinones dihydro compounds and the method that contains the pharmaceutical composition of this compound 1987-04-01 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250214920-A1 METHOD FOR PRODUCING CYCLIC DIKETONE COMPOUND CYP4F2, DUOX1, BCKDK CA12 1156/4885CA1 1048/4885CA2 2198/4885
US-20060222675-A1 Personal care compositions with color changing indicator CUTA, POLR1C, TYR CA12 2044/4885CA1 1814/4885CA2 253/4885
US-20060257439-A1 Cleansing compositions with color changing indicator WASHC5, WASHC4, FHIT CA12 15/4885CA1 139/4885CA2 30/4885
US-20250214921-A1 METHOD FOR PRODUCING CYCLIC DIKETONE COMPOUND HSD17B7, HSD17B12, BCKDK CA12 2616/4885CA1 2942/4885CA2 3272/4885
US-20060222601-A1 Oral care compositions with color changing indicator CA9, CA7, TAS2R7 CA12 38/4885CA1 70/4885CA2 29/4885
US-20070010400-A1 Use of color changing indicators in consumer products NQO2, CA4, CA7 CA12 16/4885CA1 208/4885CA2 7/4885
US-20060236470-A1 Novelty compositions with color changing indicator MITF, CRABP2, SHH CA12 997/4885CA1 1914/4885CA2 2888/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.